Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Recruiting Phase 2 Interventional Study
HPV (Human Papillomavirus)-Associated Genital Warts
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
KTH Biopharma · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. 18 years of age or older. 2. Able to read and understand the Patient Information Sheet and the Informed Consent form. 3. Acceptance in the participation of the essay and signature of the Informed Consent form. 4. Diagnosis of genital and anal warts with clear clinical manifes…
Contacts

Thanh Tam Tran, MD

+84383744842

Tranthanhtam.fmh@gmail.com

CONTACT